Modulight is a technology company focused on the design and manufacture of lasers and optics with a strategic focus on medical and biomedical applications. Modulight's growth story was interrupted after the 2021 IPO and the company is now looking to get back on track for profitable growth with a renewed strategy. We expect the company to deliver strong growth, although the visibility of the forecast is weak. Our valuation that relies on sales-based ratios and cash flows suggests the stock being moderately overvalued.